Febrile Seizures: An Updated Narrative Review for Pediatric Ambulatory Care Providers

James Sze-Chuck Leung1

  • 1Department of Pediatrics, Division of Pediatric Emergency Medicine, McMaster University, Hamilton, Ontario, Canada.

Insights

Febrile seizures in children are often self-limited but cause distress. Pediatric providers should counsel families on causes, risks, and management of febrile seizures, focusing on prognosis and when to seek further care.

Area of Science:

  • Pediatric Neurology
  • Clinical Pediatrics

Background:

  • Febrile seizures, though generally self-limited, cause significant family anxiety.
  • Ambulatory pediatric care providers need updated information on febrile seizure management for effective family counseling.

Approach:

  • A narrative review of the literature was conducted.
  • Prioritization was given to landmark articles, meta-analyses, longitudinal cohort studies, and national guidelines.

Key Points:

  • Febrile seizures result from complex interactions of neuroinflammation, environmental factors, and genetics.
  • Routine investigations like bloodwork, lumbar punctures, neuroimaging, and EEGs have low diagnostic yield.
  • While prognosis is generally excellent, complex febrile seizures are associated with cognitive impairment, neuropsychiatric issues, and epilepsy risk.

Conclusions:

  • Management priorities include seizure termination, differential diagnosis, fever etiology investigation, and family counseling.
  • Non-simple febrile seizures (complex or status epilepticus) require closer monitoring than simple febrile seizures.
  • Intermittent oral diazepam may benefit high-risk children or those with parental anxiety.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
563
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
734
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
259
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
859
Patterns of Fever01:26

Patterns of Fever

Before understanding the types and patterns of fever, it is essential to know its phases.
2.9K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
422